Integra LifeSciences Holdings (IART) — Free Cash Flow Generation Index
Integra LifeSciences Holdings (IART) has a Free Cash Flow Generation Index of -0.51x as of March 2026. Free cash flow of $-5.04 Million represents -1% of operating cash flow ($9.80 Million). Explore capital reinvestment ratio of Integra LifeSciences Holdings to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Integra LifeSciences Holdings Free Cash Flow Generation Index (1999–2025)
Historical FCF Generation Index trend for Integra LifeSciences Holdings across 26 annual periods. For the full cash flow conversion analysis, see Integra LifeSciences Holdings (IART) cash flow conversion.
Annual Free Cash Flow Generation for Integra LifeSciences Holdings (1999–2025)
Year-by-year Free Cash Flow Generation Index for Integra LifeSciences Holdings. Check cash flow reinvestment rate of Integra LifeSciences Holdings to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.62x | $-31.05 Million | $50.38 Million | $81.44 Million | ▼ -419.4% |
| 2024 | 0.19x | $24.96 Million | $129.38 Million | $104.42 Million | ▼ -63.1% |
| 2023 | 0.52x | $73.09 Million | $139.96 Million | $66.86 Million | ▼ -36.5% |
| 2022 | 0.82x | $217.38 Million | $264.47 Million | $47.09 Million | ▼ -2.9% |
| 2021 | 0.85x | $264.35 Million | $312.43 Million | $48.08 Million | ▲ +23.2% |
| 2020 | 0.69x | $139.94 Million | $203.83 Million | $63.89 Million | ▲ +64.0% |
| 2019 | 0.42x | $96.90 Million | $231.43 Million | $134.53 Million | ▼ -31.4% |
| 2018 | 0.61x | $121.94 Million | $199.68 Million | $77.74 Million | ▼ -1.5% |
| 2017 | 0.62x | $71.04 Million | $114.54 Million | $43.50 Million | ▲ +4.5% |
| 2016 | 0.59x | $69.08 Million | $116.41 Million | $47.33 Million | ▼ -8.2% |
| 2015 | 0.65x | $61.07 Million | $94.48 Million | $33.41 Million | ▲ +38.6% |
| 2014 | 0.47x | $37.07 Million | $79.46 Million | $42.40 Million | ▲ +358.7% |
| 2013 | 0.10x | $5.42 Million | $53.27 Million | $47.85 Million | ▲ +157.9% |
| 2012 | -0.18x | $-10.32 Million | $58.72 Million | $69.03 Million | ▼ -127.8% |
| 2011 | 0.63x | $65.90 Million | $104.33 Million | $38.42 Million | ▼ -2.5% |
| 2010 | 0.65x | $68.43 Million | $105.57 Million | $37.14 Million | ▼ -19.7% |
| 2009 | 0.81x | $115.67 Million | $143.24 Million | $27.57 Million | ▼ -1.0% |
| 2008 | 0.82x | $59.19 Million | $72.59 Million | $13.40 Million | ▲ +56.8% |
| 2007 | 0.52x | $24.45 Million | $47.03 Million | $22.57 Million | ▼ -38.0% |
| 2006 | 0.84x | $60.18 Million | $71.70 Million | $11.52 Million | ▼ -2.2% |
| 2005 | 0.86x | $48.80 Million | $56.85 Million | $8.05 Million | ▲ +9.8% |
| 2004 | 0.78x | $30.47 Million | $38.98 Million | $8.51 Million | ▼ -12.1% |
| 2003 | 0.89x | $30.98 Million | $34.83 Million | $3.84 Million | ▼ -4.3% |
| 2002 | 0.93x | $29.73 Million | $31.98 Million | $2.25 Million | ▲ +13.7% |
| 2001 | 0.82x | $12.84 Million | $15.70 Million | $2.86 Million | ▲ +113.8% |
| 1999 | -5.92x | $-14.80 Million | $2.50 Million | $17.30 Million | — |